Alain Herrera
Director/Board Member bij NANOBIOTIX
Oorsprong van het eerstegraads netwerk van Alain Herrera
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
47
| Public Company | Miscellaneous Commercial Services | 47 |
24
| Public Company | Medical Specialties | 24 |
| Public Company | Pharmaceuticals: Major | 23 | |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France.
8
| Holding Company | Pharmaceuticals: Major | 8 |
International Drug Development Institute SA
 International Drug Development Institute SA Miscellaneous Commercial ServicesCommercial Services International Drug Development Institute SA engages in the provision of biostatistics and electronical-clinical solutions for phase I-IV clinical trials. It offers oncology clinical research, consultancy, clinical data management, data standards implementation and randomization services. The company was founded by Marc Buyse in 1991 and is headquartered in Louvain-la-Neuve, Belgium.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Onward Therapeutics SA
 Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston.
3
| Private Company | Biotechnology | 3 |
Gustave Roussy Foundation
 Gustave Roussy Foundation Hospital/Nursing ManagementHealth Services Gustave Roussy Foundation is a leading European cancer center that specializes in the treatment of rare cancers and complex tumors. Gustave Roussy Foundation is located in Villejuif and Chevilly-Larue, France, and has 3,200 health professionals and 4,100 professionals working on its two campuses. The institute provides expert care for all cancers at every stage of life and caters to almost 50,000 patients per year. It is a source of diagnostic and therapeutic advances and integrates research, patient care, and teaching. The institute offers personalized management that combines innovation and a human-focused approach, taking into account care and physical, psychological, and social quality of life.
3
| Private Company | Hospital/Nursing Management | 3 |
EMERCell SAS
 EMERCell SAS Pharmaceuticals: MajorHealth Technology EMERCell SAS is an oncology company based in Montpellier, France. The French company is focused on developing a platform technology to produce off-the-shelf allogenic natural killer (NK) cells. The company's lead drug candidate, NK-001, is intended for the treatment of lymphoma patients who are refractory to conventional therapies. EMERCell collaborates with numerous industrial and academic partners and has received support from the Occitanie region (ADI) and Bpifrance. The company was founded in 2013 by Patrick Henno and Martin Villalba and is a member of Eurobiomed.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Alain Herrera via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Washington University in St. Louis | College/University | Graduate Degree Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AXA | Multi-Line Insurance | Director/Board Member Chief Operating Officer | |
| VEOLIA ENVIRONNEMENT | Water Utilities | Director/Board Member Corporate Officer/Principal | |
| TOTALENERGIES SE | Integrated Oil | Chairman Director of Finance/CFO | |
Total Holdings SAS
 Total Holdings SAS Wholesale DistributorsDistribution Services Total Holdings SAS provides oil refining and marketing services. The company was founded on October 10, 1955 and is headquartered in Courbevoie, France. | Wholesale Distributors | Chief Executive Officer Director/Board Member | |
| KERING | Consumer Sundries | Director/Board Member Corporate Officer/Principal | |
Société Régionale d'Investissement de Wallonie SA
 Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance Société Régionale d'Investissement de Wallonie SA (SRIW) is a private equity & venture capital firm , a subsidiary of Region of Wallonia founded in 1979. Société Régionale d'Investissement de Wallonie SA is headquartered in Liege, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| INSEAD | College/University | Director/Board Member Masters Business Admin Masters Business Admin | |
| Chalmers University of Technology | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree | |
| Stockholm School of Economics | College/University | Corporate Officer/Principal Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
| THERADIAG | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Graduate Degree | |
| Université Libre de Bruxelles | College/University | Graduate Degree Doctorate Degree | |
| Université Paris Dauphine-PSL | College/University | Undergraduate Degree Graduate Degree | |
| Sciences Po | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ESSEC Business School | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
| Ecole Polytechnique | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Graduate Degree | |
| Arts Et Metiers Paristech | College/University | Chairman Undergraduate Degree | |
| École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Masters Business Admin Corporate Officer/Principal | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Musée du Louvre
 Musée du Louvre Other Consumer ServicesConsumer Services Musée du Louvre is a world-renowned art museum located in Paris, France. The museum is home to an extensive collection of art and artifacts from around the world, including famous works such as the Mona Lisa and the Venus de Milo. The Musée du Louvre is a subsidiary of the French Ministry of Culture and ultimately controlled by the Government of France. | Other Consumer Services | Director/Board Member Director/Board Member | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Sorbonne Université | College/University | Undergraduate Degree Graduate Degree | |
| EUROBIO SCIENTIFIC | Medical Specialties | Corporate Officer/Principal Chairman | |
MaSTherCell SA
 MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| CANSINO BIOLOGICS INC. | Biotechnology | Founder Corporate Officer/Principal | |
| Axa Research Fund | Corporate Officer/Principal Founder | ||
Bioxodes SA
 Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PDC Line Pharma SA
 PDC Line Pharma SA Pharmaceuticals: MajorHealth Technology Part of PDC Line Pharma SASU, PDC Line Pharma is a Belgian company that focuses on medical needs, particularly on skin cancer, which is the most lethal form of cancer worldwide. The private company is based in Liege, Belgium, and has two drug candidates in its pipeline, one for melanoma and another for lung cancer. The company aims to address this issue by developing drug candidates that can bring positive results to patients. PDC Line Pharma was founded in 2016 by Laurent Levy and Joel Plumas, and its CEO is Eric Halioua. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder Founder | |
Clinimetrics SA
 Clinimetrics SA Miscellaneous Commercial ServicesCommercial Services Clinimetrics SA provides market research services. The private company is based in Rixensart, Belgium. The Belgian company was founded in 1985. Marc Buyse has been the CEO of the company since 2007. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 29 |
| België | 11 |
| Zweden | 5 |
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Consumer Services | 23 |
| Health Technology | 16 |
| Finance | 4 |
| Energy Minerals | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 429 |
| Corporate Officer/Principal | 206 |
| Chairman | 148 |
| Independent Dir/Board Member | 93 |
| Chief Executive Officer | 92 |
Sterkste connecties
| Insiders | |
|---|---|
| Sébastien Bazin | 65 |
| Véronique Denise Lebey Weill | 49 |
| François Fontaine | 34 |
| Jean-Paul Prieels | 32 |
| Jean Bizzari | 24 |
| Robert Castaigne | 23 |
| Anna Belfrage | 23 |
| Anne-Marie Graffin | 22 |
| Jean-René Fourtou | 21 |
| Arthur Charles V. Wellesley | 21 |
| Lesa Mitchell | 20 |
| Jan-Eric Österlund | 20 |
| Gary Phillips | 20 |
| Thierry Desmarest | 20 |
| Lennart Christer Jeansson | 20 |
- Beurs
- Insiders
- Alain Herrera
- Bedrijfsconnecties
